Orthofix Medical Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-92.2M | $-126.0M | $-151.4M | $-19.7M | $-38.4M | $2.5M | $-28.5M | $13.8M |
| Depreciation & Amortization | $77.3M | $60.1M | $53.1M | $29.0M | $29.6M | $30.5M | $24.7M | $18.7M |
| Depreciation | $47.3M | $41.1M | $34.2M | $19.6M | $20.2M | $19.3M | $17.7M | $15.9M |
| Amortization | $30.0M | $19.0M | $18.9M | $9.4M | $9.4M | $11.2M | $7.0M | $2.7M |
| Stock-Based Compensation | $28.7M | $32.5M | $35.7M | $18.4M | $15.4M | $16.2M | $21.5M | $18.9M |
| Net Cash from Operating Activities | $33.3M | $25.8M | $-45.8M | $-11.5M | $18.5M | $74.3M | $32.0M | $49.9M |
| Investing Activities | ||||||||
| Capital Expenditures | $34.6M | $34.9M | $60.3M | $21.4M | $17.8M | $15.5M | $19.0M | $13.6M |
| Business Acquisitions | — | — | — | — | — | $18.0M | — | $44.3M |
| Net Cash from Investing Activities | $-34.6M | $-27.6M | $-33.1M | $-24.5M | $-23.0M | $-52.3M | $-22.9M | $-61.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-786.0K | $50.7M | $65.3M | $-78.0K | $-3.6M | $3.2M | $-10.7M | $3.0M |
| Net Change in Cash | $-623.0K | $48.0M | $-12.9M | $-37.1M | $-9.0M | $26.4M | $-1.8M | $-9.0M |
| Free Cash Flow | $-1.3M | $-9.1M | $-106.0M | $-32.9M | $690.0K | $58.8M | $13.0M | $36.3M |